Serum growth hormone binding protein and hepatic GH binding sites in the Lewis dwarf rat: effects of IGF-I and GH. 1994

R Barnard, and J Mulcahy, and J García-Aragón, and B Wyse, and P C Owens, and S W Rowlinson, and F Talamantes, and W R Baumbach, and M J Waters
Department of Physiology and Pharmacology, University of Queensland, St Lucia, Australia.

A radioimmunoassay (RIA) for the rat growth hormone binding protein (GHBP) was developed using a synthetic peptide (corresponding to the hydrophilic carboxyl-terminal sequence of mouse GHBP) as standard and a monoclonal antibody (MAb 4.3) reactive with this peptide as the primary antibody. The values for GHBP concentration obtained for normal rats using this assay compare favourably with those obtained by gel filtration and ELISA methods. The concentration of GHBP in normal male rats at 11 weeks of age (680 +/- 30 ng/ml, SEM, n = 9) was significantly less than the concentration in normal females (943 +/- 47 ng/ml, SEM, n = 25). In 11-week-old dwarf male rats the concentration of GHBP was 423 +/- 35 ng/ml (n = 8); less than in dwarf females (542 +/- 32, P < 0.05, n = 9) and normal males (680 +/- 30, P < 0.001, n = 9). The GHBP concentration in dwarf rats was not age-dependent, whereas in normal females the concentration of GHBP increased with age. The availability of an RIA which is not susceptible to interference by endogenous GH, will facilitate further studies on hormonal and nutritional regulation of the rat GHBP. The assay was applied to studying the effects of IGF-I infusion (240 micrograms/day for 1 week) and GH injection (65 micrograms/100 g body weight, twice daily for 1 week and 4 weeks) on the serum concentration of GHBP in 11-week-old Lewis dwarf rats. Hepatic GH binding sites were also measured in desaturated membranes from the same animals.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D011917 Rats, Inbred Lew An inbred strain of rat that is used in BIOMEDICAL RESEARCH. Rats, Inbred Lewis,Rats, Lew,Inbred Lew Rat,Inbred Lew Rats,Inbred Lewis Rats,Lew Rat,Lew Rat, Inbred,Lew Rats,Lew Rats, Inbred,Lewis Rats, Inbred,Rat, Inbred Lew,Rat, Lew
D011986 Receptors, Somatotropin Cell surface proteins that bind GROWTH HORMONE with high affinity and trigger intracellular changes influencing the behavior of cells. Activation of growth hormone receptors regulates amino acid transport through cell membranes, RNA translation to protein, DNA transcription, and protein and amino acid catabolism in many cell types. Many of these effects are mediated indirectly through stimulation of the release of somatomedins. Growth Hormone Receptors,Receptors, Growth Hormone,Somatomammotropin Receptors,Somatotropin Receptors,Growth Hormone Receptor,Receptor, Growth Hormone,Receptors, Somatomammotropin,Somatomammotropin Receptor,Somatotropin Receptor,Hormone Receptor, Growth,Hormone Receptors, Growth
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D002850 Chromatography, Gel Chromatography on non-ionic gels without regard to the mechanism of solute discrimination. Chromatography, Exclusion,Chromatography, Gel Permeation,Chromatography, Molecular Sieve,Gel Filtration,Gel Filtration Chromatography,Chromatography, Size Exclusion,Exclusion Chromatography,Gel Chromatography,Gel Permeation Chromatography,Molecular Sieve Chromatography,Chromatography, Gel Filtration,Exclusion Chromatography, Size,Filtration Chromatography, Gel,Filtration, Gel,Sieve Chromatography, Molecular,Size Exclusion Chromatography
D004392 Dwarfism A genetic or pathological condition that is characterized by short stature and undersize. Abnormal skeletal growth usually results in an adult who is significantly below the average height. Nanism
D004435 Eating The consumption of edible substances. Dietary Intake,Feed Intake,Food Intake,Macronutrient Intake,Micronutrient Intake,Nutrient Intake,Nutritional Intake,Ingestion,Dietary Intakes,Feed Intakes,Intake, Dietary,Intake, Feed,Intake, Food,Intake, Macronutrient,Intake, Micronutrient,Intake, Nutrient,Intake, Nutritional,Macronutrient Intakes,Micronutrient Intakes,Nutrient Intakes,Nutritional Intakes

Related Publications

R Barnard, and J Mulcahy, and J García-Aragón, and B Wyse, and P C Owens, and S W Rowlinson, and F Talamantes, and W R Baumbach, and M J Waters
January 1995, The Journal of clinical endocrinology and metabolism,
R Barnard, and J Mulcahy, and J García-Aragón, and B Wyse, and P C Owens, and S W Rowlinson, and F Talamantes, and W R Baumbach, and M J Waters
December 1992, The Journal of endocrinology,
R Barnard, and J Mulcahy, and J García-Aragón, and B Wyse, and P C Owens, and S W Rowlinson, and F Talamantes, and W R Baumbach, and M J Waters
May 1994, Molecular and cellular endocrinology,
R Barnard, and J Mulcahy, and J García-Aragón, and B Wyse, and P C Owens, and S W Rowlinson, and F Talamantes, and W R Baumbach, and M J Waters
July 1998, The Journal of clinical endocrinology and metabolism,
R Barnard, and J Mulcahy, and J García-Aragón, and B Wyse, and P C Owens, and S W Rowlinson, and F Talamantes, and W R Baumbach, and M J Waters
September 1994, The American journal of physiology,
R Barnard, and J Mulcahy, and J García-Aragón, and B Wyse, and P C Owens, and S W Rowlinson, and F Talamantes, and W R Baumbach, and M J Waters
April 1997, Endocrine,
R Barnard, and J Mulcahy, and J García-Aragón, and B Wyse, and P C Owens, and S W Rowlinson, and F Talamantes, and W R Baumbach, and M J Waters
May 1996, Endocrinology,
R Barnard, and J Mulcahy, and J García-Aragón, and B Wyse, and P C Owens, and S W Rowlinson, and F Talamantes, and W R Baumbach, and M J Waters
August 1994, Clinical endocrinology,
R Barnard, and J Mulcahy, and J García-Aragón, and B Wyse, and P C Owens, and S W Rowlinson, and F Talamantes, and W R Baumbach, and M J Waters
May 1994, Endocrinology,
R Barnard, and J Mulcahy, and J García-Aragón, and B Wyse, and P C Owens, and S W Rowlinson, and F Talamantes, and W R Baumbach, and M J Waters
May 1998, Clinical endocrinology,
Copied contents to your clipboard!